Dr. Louise Provencher is a surgeon-oncologist at the CHU de Québec-Laval University. She is also a clinical researcher at the Research Center of the CHU de Québec-Laval University, and clinical professor at the Laval University School of Medicine. Dr. Provencher is part of the research group of the Centre des Maladies du Sein of CHU de Québec-Laval University.

Dr. Provencher is a scientific committee member at the McPeak-Sirois research group and the CHU de Quebec leader for the National Surgical Adjuvant Breast and Bowel Project.

Using structured breast cancer data

The Centre des Maladies du Sein research team has a comprehensive database of all cancers diagnosed since 1974; more than 12,000 patients are listed. A database of biopsy data from 1999 is also available; data on more than 34,000 biopsies are listed. These databases allow quality publications that modify the management and follow-up of cancers and benign breast diseases.

Offer innovative treatments

The Centre des Maladies du Sein of CHU de Québec-Laval University research group is one of the largest in Canada offering innovative treatments for breast cancer. More than 50 clinical trials are active at all times and are offered to patients who consult at the clinic or are referred by clinics/hospitals in the area. These clinical trials provide access to innovative experimental medications and develop the expertise of our world-renowned oncologists.

Supporting quality of life

The Centre des Maladies du Sein of CHU de Québec-University research group is a pioneer in quality of life studies in breast cancer, from total mastectomy to partial mastectomy, to the use of the cooling cap to counteract hair loss, promoting physical activity to improve survivorship, including optimal preservation of the axillary lymph nodes. The research group is at the forefront of studies promoting quality of life despite the adverse effects of the disease on an individual’s life.

Hôpital Saint-Sacrement
1050, chemin Sainte-Foy
Centre des maladies du sein Deschênes-Fabia
Québec, Québec
Canada G1S 4L8
+1 418-682-7511
Louise.Provencher@chudequ... louise.provencher@crchude...

Latest news

78 entries « ‹ 1 of 8 › »

Gagnet S, Diorio C, Provencher L, Mbuya-Bienge C, Lapointe J, Morin C, Lemieux J, Nabi H

Identifying Clinicopathological Factors Associated with Oncotype DX 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, Canada.

Journal Article

J Pers Med, 11 (9), 2021.

Abstract | Links:

Wardley A, Cortes J, Provencher L, Miller K, Chien AJ, Rugo HS, Steinberg J, Sugg J, Tudor IC, Huizing M, Young R, Abramson V, Bose R, Hart L, Chan S, Cameron D, Wright GS, Graas MP, Neven P, Rocca A, Russo S, Krop IE

The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.

Journal Article

Breast Cancer Res Treat, 187 (1), 2021.

Abstract | Links:

Ennour-Idrissi K, Dragic D, Issa E, Michaud A, Chang SL, Provencher L, Durocher F, Diorio C

DNA Methylation and Breast Cancer Risk: An Epigenome-Wide Study of Normal Breast Tissue and Blood.

Journal Article

Cancers (Basel), 12 (11), 2020.

Abstract | Links:

Labonte M, Guillaumie L, Dionne A, Dorval M, Nabi H, Lemieux J, Provencher L, Lauzier S

Development of a community pharmacy-based intervention to enhance adherence to adjuvant endocrine therapy among breast cancer survivors guided by the Intervention Mapping approach.

Journal Article

Res Social Adm Pharm, 16 (12), 2020.

Abstract | Links:

Fehrenbacher L, Cecchini RS, Geyer Jr, Rastogi P, Costantino JP, Atkins JN, Crown JP, Polikoff J, Boileau JF, Provencher L, Stokoe C, Moore TD, Robidoux A, Flynn PJ, Borges VF, Albain KS, Swain SM, Paik S, Mamounas EP, Wolmark N

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.

Journal Article

J Clin Oncol, 38 (5), 2020.

Abstract | Links:

Ruel S, Ivers H, Savard MH, Gouin JP, Lemieux J, Provencher L, Caplette-Gingras A, Bastien C, Morin CM, Couture F, Savard J

Insomnia, immunity, and infections in cancer patients: Results from a longitudinal study.

Journal Article

Health Psychol, 39 (5), 2020.

Abstract | Links:

Humphries B, Lauzier S, Drolet M, Coyle D, Masse B, Provencher L, Robidoux A, Maunsell E

Wage losses among spouses of women with nonmetastatic breast cancer.

Journal Article

Cancer, 126 (5), 2020.

Abstract | Links:

Corter AL, Speller B, McBain K, Wright FC, Quan ML, Kennedy E, Schmocker S, Baxter NN, Provencher L

Evaluating A Multidisciplinary Cancer Conference Checklist: Practice Versus Perceptions.

Journal Article

J Multidiscip Healthc, 12 , 2019.

Abstract | Links:

von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wulfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer Jr, Provencher L, Fein L, Kaen L, Lerzo G, Egle D, Greil R, Hubalek M, Singer C, Steger G, Dirix L, Duhoux F, Jerusalem G, Renard V, Araujo R, Boukai A, Hegg R, Lima JP, Morelle A, Muller AP, Paiva CE, Pedrini JL, Pinczowski H, Santos L, Teich NL, Testa L, Wiermann E, Basik M, Davidson JA, Goel R, Logan D, Lohrisch C, Mackey J, Martin LA, Paterson A, Prady C, Robidoux A, Sridhar S, Thirlwell M, Tonkin K, Warr D, Li W, Liao N, Pang D, Shen K, Wang S, Franco S, Gonzalez M, Quiroga Echeverri A, Yepes A, Kubala E, Melichar B, Paulik A, Zimovjanova M, Bonnefoi H, Bourgeois H, Brain E, Curtit E, D'Hondt V, Dieras V, Espie M, Extra JM, Gligorov J, Grenier J, Levy C, Mouret-Reynier MA, Nabholtz JM, Orfeuvre H, Petit T, Pierga JY, Pivot X, Romieu G, Saghatchian-D'Assignies M, Teixeira L, Thery JC, Veyret C, Aktas B, Bauer S, Belau A, Blohmer JU, Eidtmann H, Fehm T, Feisel-Schwickardi G, Gerteis A, Grafe A, Graffunder G, Grischke EM, Hackmann J, Harbeck N, Heinrich B, Hielscher C, Hoffmann O, Janni W, Just M, Klare P, Kronawitter U, Kühn T, Kümmel S, Kunz G, Lantzsch T, Lübbe K, Meinerz W, Mundhenke C, Negwer M, Neunhöffer T, Overkamp F, Park-Simon TW, Rack B, Rautenberg B, Reimer T, Rezai M, Salat C, Schem C, Schlag R, Schmatloch S, Schnappauf B, Schrauder M, Schumacher C, Schwaner I, Solbach C, Stickeler E, Tesch H, Thalmann I, Thomssen C, Wachsmann GT, Warm M, Wiebringhaus H, Mavroudis D, Papazisis K, Castro-Salguero H, Hernandez-Monroy CE, Cheung FY, Kwong A, Ng TY, Soong SI, Coate L, Hennessy B, Higgins M, Keane M, Kelly C, Moylan E, Nasim S, O'Reilly S, Ben Baruch N, Geffen D, Kaufman B, Rosengarten O, Uziely B, Yerushalmi R, Allegrini G, Bianchi G, Brandes A, Cazzaniga M, Cinieri S, Colleoni MA, Conte PF, De Laurentiis M, De Placido S, Del Mastro L, Fiorio E, Fontana A, Generali D, Gianni L, Marchetti P, Molino AM, Montemurro F, Tonini G, Zamagni C, Arce Salinas C, Chavarri Guerra Y, Hernandez CA, Lopez-Lopez F, Martinez G, Villarreal Garza CM

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

Journal Article

N Engl J Med, 380 (7), 2019.

Abstract | Links:

Leblond MA, Duchesne N, Provencher L, Hogue JC, Pinault S

Is contralateral breast ultrasound worthwhile in preoperative staging of breast cancer?

Journal Article

J Clin Ultrasound, 47 (4), 2019.

Abstract | Links:

78 entries « ‹ 1 of 8 › »
Signaler des ajouts ou des modifications

Active projects

  • A phase II randomized study evaluating the biological and clinical effects of the combination of palbociclib with letrozole as neoadjuvant therapy in women with estrogen receptor-positive primary breast cancer, from 2016-03-30 to 2025-12-25
  • Effect of environmental contaminants and methylome of breast adipose tissue on aromatase inhibitor efficacy in breast cancer, from 2016-07-01 to 2024-09-30
  • NSABP Breast Cancer Treatment Protocols, from 1997-02-01 to 2025-12-25
  • Omega-3 fatty acids in the prevention of breast cancer: role of obesity-related markers in breast tissues, from 2018-10-01 to 2026-09-30
  • Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, from 2019-10-01 to 2022-02-28
  • Towards better outcomes for young women with breast cancer : A pan-canadian collaborative - Reducing the bUrden of Breast cancer in Young women (RUBY), from 2016-03-10 to 2025-12-25
  • Utilisation de l'intelligence artificielle (IA) afin de prédire les résultats de biopsies faites pour les mammographies anormales avec comme but ultime de réduire le nombre de biopsies , from 2019-12-09 to 2021-12-08
  • Utilisation de l'intelligence artificielle afin de maintenir automatiquement le registre national de suivi en cancer du sein et du projet de recherche en cancer du sein associé, from 2019-01-01 to 2021-12-31

Recently finished projects

  • Excellence in advanced cancer clinical trials initiative (the ExACCT Initiavive) , from 2017-01-18 to 2021-03-31
  • MA-12: Étude randomisée à double insu visant à comparer le tamoxifène avec un placebo chez les patientes atteintes d'un cancer du sein étendu aux ganglions lymphatiques et qui ont complété une chimiothérapie adjuvante ..., from 1997-04-01 to 2020-03-31
  • Mise à jour des connaissances en cancer du sein, from 2018-01-24 to 2021-03-31
Data provided by the Université Laval research projects registery